248 related articles for article (PubMed ID: 10187769)
41. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
[TBL] [Abstract][Full Text] [Related]
42. Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs.
Gerken TA; Ten Hagen KG; Jamison O
Glycobiology; 2008 Nov; 18(11):861-70. PubMed ID: 18669915
[TBL] [Abstract][Full Text] [Related]
43. N-acetylgalactosamine incorporation into a peptide containing consecutive threonine residues by UDP-N-acetyl-D-galactosaminide:polypeptide N-acetylgalactosaminyltransferases.
Kato K; Takeuchi H; Kanoh A; Mandel U; Hassan H; Clausen H; Irimura T
Glycobiology; 2001 Oct; 11(10):821-9. PubMed ID: 11588158
[TBL] [Abstract][Full Text] [Related]
44. Glycosylation of the tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen.
Inoue M; Yamashina I; Nakada H
Biochem Biophys Res Commun; 1998 Apr; 245(1):23-7. PubMed ID: 9535776
[TBL] [Abstract][Full Text] [Related]
45. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
[TBL] [Abstract][Full Text] [Related]
46. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
Kong Y; Joshi HJ; Schjoldager KT; Madsen TD; Gerken TA; Vester-Christensen MB; Wandall HH; Bennett EP; Levery SB; Vakhrushev SY; Clausen H
Glycobiology; 2015 Jan; 25(1):55-65. PubMed ID: 25155433
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the UDP-N-acetylgalactosamine binding domain of bovine polypeptide alphaN-acetylgalactosaminyltransferase T1.
Duclos S; Da Silva P; Vovelle F; Piller F; Piller V
Protein Eng Des Sel; 2004 Aug; 17(8):635-46. PubMed ID: 15377782
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.
Cheng L; Tachibana K; Iwasaki H; Kameyama A; Zhang Y; Kubota T; Hiruma T; Tachibana K; Kudo T; Guo JM; Narimatsu H
FEBS Lett; 2004 May; 566(1-3):17-24. PubMed ID: 15147861
[TBL] [Abstract][Full Text] [Related]
49. A vector projection method for predicting the specificity of GalNAc-transferase.
Chou KC; Zhang CT; Kézdy FJ; Poorman RA
Proteins; 1995 Feb; 21(2):118-26. PubMed ID: 7777486
[TBL] [Abstract][Full Text] [Related]
50. Influence of the amino acid sequence on the MUC5AC motif peptide O-glycosylation by human gastric UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase(s).
Hennebicq S; Tetaert D; Soudan B; Boersma A; Briand G; Richet C; Gagnon J; Degand P
Glycoconj J; 1998 Mar; 15(3):275-82. PubMed ID: 9579804
[TBL] [Abstract][Full Text] [Related]
51. The influence of flanking sequence on the O-glycosylation of threonine in vitro.
O'Connell BC; Hagen FK; Tabak LA
J Biol Chem; 1992 Dec; 267(35):25010-8. PubMed ID: 1460004
[TBL] [Abstract][Full Text] [Related]
52. Activity of partially purified UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase with different peptide acceptors.
Porowska H; Paszkiewicz-Gadek A; Gindzieński A
Acta Biochim Pol; 1999; 46(2):365-70. PubMed ID: 10547037
[TBL] [Abstract][Full Text] [Related]
53. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
54. Site-specific core 1 O-glycosylation pattern of the porcine submaxillary gland mucin tandem repeat. Evidence for the modulation of glycan length by peptide sequence.
Gerken TA; Owens CL; Pasumarthy M
J Biol Chem; 1998 Oct; 273(41):26580-8. PubMed ID: 9756896
[TBL] [Abstract][Full Text] [Related]
55. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
[TBL] [Abstract][Full Text] [Related]
56. Function of the lectin domain of polypeptide N-acetylgalactosaminyltransferase 1.
Tenno M; Kézdy FJ; Elhammer AP; Kurosaka A
Biochem Biophys Res Commun; 2002 Nov; 298(5):755-9. PubMed ID: 12419318
[TBL] [Abstract][Full Text] [Related]
57. Purification and characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase specific for glycosylation of threonine residues.
Wang Y; Abernethy JL; Eckhardt AE; Hill RL
J Biol Chem; 1992 Jun; 267(18):12709-16. PubMed ID: 1618775
[TBL] [Abstract][Full Text] [Related]
58. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
[TBL] [Abstract][Full Text] [Related]
59. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
60. Charge distribution of flanking amino acids inhibits O-glycosylation of several single-site acceptors in vivo.
Nehrke K; Ten Hagen KG; Hagen FK; Tabak LA
Glycobiology; 1997 Dec; 7(8):1053-60. PubMed ID: 9455905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
